128 related articles for article (PubMed ID: 11523171)
1. [CHF arising after low dose THP-COP chemotherapy in an elderly patient with malignant lymphoma].
Matoba-Ueno K; Fujimoto S; Doi N; Nishino T; Yamano S; Shiiki H; Hashimoto T; Nakamura S
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):548-53. PubMed ID: 11523171
[TBL] [Abstract][Full Text] [Related]
2. R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
Hara T; Yoshikawa T; Goto H; Sawada M; Yamada T; Fukuno K; Kasahara S; Shibata Y; Matsumoto T; Mabuchi R; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Nannya Y; Katsumura N; Takahashi T; Kito Y; Takami T; Miyazaki T; Takeuchi T; Shimizu M; Tsurumi H
Hematol Oncol; 2018 Oct; 36(4):638-644. PubMed ID: 29882279
[TBL] [Abstract][Full Text] [Related]
3. [A case of primary hepatic lymphoma successfully treated by THP-COP therapy].
Takauchi K; Kono H; Ito T; Zaima K; Okumoto S
Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):65-8. PubMed ID: 12649851
[TBL] [Abstract][Full Text] [Related]
4. 3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.
Araie H; Sakamaki I; Matsuda Y; Tai K; Ikegaya S; Itoh K; Kishi S; Oiwa K; Okura M; Tasaki T; Hosono N; Ueda T; Yamauchi T
Intern Med; 2017 Sep; 56(18):2407-2413. PubMed ID: 28824057
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
Mori M; Kitamura K; Masuda M; Hotta T; Miyazaki T; Miura AB; Mizoguchi H; Shibata A; Saito H; Matsuda T; Masaoka T; Harada M; Niho Y; Takaku F
Int J Hematol; 2005 Apr; 81(3):246-54. PubMed ID: 15814336
[TBL] [Abstract][Full Text] [Related]
6. [A case of primary malignant lymphoma of the duodenum successfully treated with dose escalating chemotherapy].
Oshiro A; Nagasaki A; Nakachi A; Uchima N; Hasegawa H; Nakazato T; Nakamoto M; Kinjo N; Kinjo F; Taira N; Masuda M; Takasu N
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1169-73. PubMed ID: 12938276
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma.
Tsurumi H; Hara T; Goto N; Kitagawa J; Kanemura N; Yoshikawa T; Kasahara S; Goto H; Fukuno K; Yamada T; Sawada M; Shimizu M; Takahashi T; Takami T; Moriwaki H
Leuk Lymphoma; 2012 Feb; 53(2):247-53. PubMed ID: 21827339
[TBL] [Abstract][Full Text] [Related]
8. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
Shibata Y; Hara T; Kasahara S; Yamada T; Sawada M; Mabuchi R; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Kito Y; Goto N; Miyazaki T; Takami T; Takeuchi T; Shimizu M; Tsurumi H
Hematol Oncol; 2017 Jun; 35(2):163-171. PubMed ID: 26449182
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of the tetrahydropyranyl adriamycin-cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma.
Kasahara S; Hara T; Tsurumi H; Goto N; Kitagawa J; Kanemura N; Yoshikawa T; Goto H; Fukuno K; Yamada T; Sawada M; Takahashi T; Takami T; Moriwaki H
Leuk Lymphoma; 2011 Apr; 52(4):629-34. PubMed ID: 21438831
[TBL] [Abstract][Full Text] [Related]
10. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
11. Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly.
Kitamura K; Takaku F
Am J Clin Oncol; 1990; 13 Suppl 1():S15-9. PubMed ID: 2291455
[TBL] [Abstract][Full Text] [Related]
12. [A case of malignant lymphoma of the stomach in which preoperative chemotherapy provided a complete response].
Okumoto T; Tomiyama K; Ino H; Kanaya Y; Maruyama S; Otani J; Yokoyama N; Soda M
Gan To Kagaku Ryoho; 2002 Jun; 29(6):943-7. PubMed ID: 12090049
[TBL] [Abstract][Full Text] [Related]
13. Effect of pirarubicin for elderly patients with malignant lymphoma.
Aoki S; Tsukada N; Nomoto N; Maruyama S; Takahashi M; Moriyama Y; Shibata A; Aizawa Y
J Exp Clin Cancer Res; 1998 Dec; 17(4):465-70. PubMed ID: 10089069
[TBL] [Abstract][Full Text] [Related]
14. Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.
Tsurumi H; Yamada T; Sawada M; Kasahara S; Kanemura N; Kojima Y; Fukuno K; Hara T; Saio M; Takahashi T; Oyama M; Ozawa K; Takami T; Moriwaki H
J Cancer Res Clin Oncol; 2004 Feb; 130(2):107-13. PubMed ID: 14648210
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphoma.
Ohnishi K; Ohmachi K; Ando K; Yamamoto K; Ito T; Tanimoto M; Ohbayashi K; Ohyashiki K; Tsukasaki K; Naito K; Suzuki T; Ono T; Miyamura K; Kagami Y; Kinoshita T; Hotta T; Ogura M
J Clin Exp Hematop; 2021 Sep; 61(3):162-167. PubMed ID: 34193755
[TBL] [Abstract][Full Text] [Related]
16. [A case of malignant lymphoma of the prostate].
Miyahara T; Oyabul Y; Hayashi T; Shimizu S; Tanaka H; Matsuoka K
Nihon Hinyokika Gakkai Zasshi; 2005 Sep; 96(6):644-6. PubMed ID: 16218408
[TBL] [Abstract][Full Text] [Related]
17. [Cure by THP-COP therapy in patients with perforated T-cell type malignant lymphoma of the jejunum].
Kajiura Y; Ogoshi K; Nakamura K; Miyaji M; Kondo Y; Makuuchi H; Tajima T; Oobayashi Y; Masumoto A; Horiki T; Suzuki T
Gan To Kagaku Ryoho; 1998 Feb; 25(3):413-7. PubMed ID: 9492837
[TBL] [Abstract][Full Text] [Related]
18. [Case of malignant lymphoma associated with rheumatoid arthritis].
Noguchi T; Nohara J; Sakaguchi Y; Kono T; Terada Y
Nihon Kokyuki Gakkai Zasshi; 2008 Feb; 46(2):131-5. PubMed ID: 18318257
[TBL] [Abstract][Full Text] [Related]
19. [Pirarubicin-induced myocardial damage in elderly patients with non-Hodgkin's lymphoma].
Niitsu N; Yamazaki J; Nakayama M; Umeda M
Nihon Ronen Igakkai Zasshi; 1998 May; 35(5):358-62. PubMed ID: 9735010
[TBL] [Abstract][Full Text] [Related]
20. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
